Literature DB >> 19230866

Depletion of the programmed death-1 receptor completely reverses established clonal anergy in CD4(+) T lymphocytes via an interleukin-2-dependent mechanism.

Kenneth D Bishop1, John E Harris, John P Mordes, Dale L Greiner, Aldo A Rossini, Michael P Czech, Nancy E Phillips.   

Abstract

Recent studies have implicated the cell surface receptor Programmed Death-1 (PD-1) in numerous models of T cell anergy, though the specific mechanisms by which the PD-1 signal maintains tolerance is not clear. We demonstrate that the depletion of PD-1 with siRNA results in a complete reversal of clonal anergy in the A.E7 T cell model, suggesting that the mechanism by which PD-1 maintains the anergic phenotype is a T-cell-intrinsic phenomenon, and not one dependent on other cell populations in vivo. We have also shown that the neutralization of IL-2 during restimulation abrogates the effect of PD-1 depletion, suggesting that tolerance mediated by PD-1 is wholly IL-2 dependent, and likewise intrinsic to the tolerized cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19230866      PMCID: PMC2876711          DOI: 10.1016/j.cellimm.2009.01.008

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  39 in total

Review 1.  The role of CD4+ T-cell subsets in determining transplantation rejection or tolerance.

Authors:  D Zelenika; E Adams; S Humm; C Y Lin; H Waldmann; S P Cobbold
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

Review 2.  Islet cell transplantation tolerance.

Authors:  A A Rossini; J P Mordes; D L Greiner; J S Stoff
Journal:  Transplantation       Date:  2001-10-27       Impact factor: 4.939

Review 3.  Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection.

Authors:  Anthony C Allison; Elsie M Eugui
Journal:  Transplantation       Date:  2005-10-15       Impact factor: 4.939

4.  PD-L2:PD-1 involvement in T cell proliferation, cytokine production, and integrin-mediated adhesion.

Authors:  Paul A Saunders; Vana R Hendrycks; William A Lidinsky; Melody L Woods
Journal:  Eur J Immunol       Date:  2005-12       Impact factor: 5.532

Review 5.  Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance.

Authors:  S Sakaguchi; N Sakaguchi; J Shimizu; S Yamazaki; T Sakihama; M Itoh; Y Kuniyasu; T Nomura; M Toda; T Takahashi
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

6.  Antibody-mediated signaling through PD-1 costimulates T cells and enhances CD28-dependent proliferation.

Authors:  María-Luisa del Rio; Giovanna Penuelas-Rivas; Raul Dominguez-Perles; Pablo Ramirez; Pascual Parrilla; Jose-Ignacio Rodriguez-Barbosa
Journal:  Eur J Immunol       Date:  2005-12       Impact factor: 5.532

7.  PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2.

Authors:  LauraL Carter; Lynette A Fouser; Jason Jussif; Lori Fitz; Bija Deng; Clive R Wood; Mary Collins; Tasuku Honjo; Gordon J Freeman; Beatriz M Carreno
Journal:  Eur J Immunol       Date:  2002-03       Impact factor: 5.532

Review 8.  PD-1 and its ligands in tolerance and immunity.

Authors:  Mary E Keir; Manish J Butte; Gordon J Freeman; Arlene H Sharpe
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 9.  Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.

Authors:  Brian T Fife; Jeffrey A Bluestone
Journal:  Immunol Rev       Date:  2008-08       Impact factor: 12.988

10.  Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation.

Authors:  G J Freeman; A J Long; Y Iwai; K Bourque; T Chernova; H Nishimura; L J Fitz; N Malenkovich; T Okazaki; M C Byrne; H F Horton; L Fouser; L Carter; V Ling; M R Bowman; B M Carreno; M Collins; C R Wood; T Honjo
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more
  10 in total

1.  Dysregulation of the PD-1/PD-L1 pathway contributes to the pathogenesis of celiac disease.

Authors:  Candelaria Ponce de León; Miguel Angel López-Casado; Pedro Lorite; Teresa Palomeque; María Isabel Torres
Journal:  Cell Mol Immunol       Date:  2019-06-26       Impact factor: 11.530

Review 2.  Genetic engineering with T cell receptors.

Authors:  Ling Zhang; Richard A Morgan
Journal:  Adv Drug Deliv Rev       Date:  2011-12-09       Impact factor: 15.470

Review 3.  Induction and stability of the anergic phenotype in T cells.

Authors:  Rut Valdor; Fernando Macian
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

Review 4.  Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer.

Authors:  Xinxin Zhu; Jinghe Lang
Journal:  Oncotarget       Date:  2017-05-31

Review 5.  PD-1 and its ligands are important immune checkpoints in cancer.

Authors:  Yinan Dong; Qian Sun; Xinwei Zhang
Journal:  Oncotarget       Date:  2017-01-10

Review 6.  Mechanisms of Tolerance Induction by Dendritic Cells In Vivo.

Authors:  Hitoshi Hasegawa; Takuya Matsumoto
Journal:  Front Immunol       Date:  2018-02-26       Impact factor: 7.561

Review 7.  Manipulation of Regulatory Dendritic Cells for Induction Transplantation Tolerance.

Authors:  Weitao Que; Wen-Zhi Guo; Xiao-Kang Li
Journal:  Front Immunol       Date:  2020-10-14       Impact factor: 7.561

Review 8.  Therapeutic Potential of Hyporesponsive CD4(+) T Cells in Autoimmunity.

Authors:  Jaxaira Maggi; Carolina Schafer; Gabriela Ubilla-Olguín; Diego Catalán; Katina Schinnerling; Juan C Aguillón
Journal:  Front Immunol       Date:  2015-09-22       Impact factor: 7.561

9.  Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression.

Authors:  Lindsay C Davies; Nina Heldring; Nadir Kadri; Katarina Le Blanc
Journal:  Stem Cells       Date:  2016-10-26       Impact factor: 6.277

10.  miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion.

Authors:  Qing Li; Nathan Johnston; Xiufen Zheng; Hongmei Wang; Xusheng Zhang; Dian Gao; Weiping Min
Journal:  Oncotarget       Date:  2016-08-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.